Ladenburg Thalmann Financial Services Inc. (NYSE MKT: LTS) today announced that David J. Strupp, Jr., a senior investment banker in the healthcare space, has joined Ladenburg Thalmann & Co. Inc. (“Ladenburg”) as a Managing Director, Healthcare Investment Banking, effective immediately. Mr. Strupp will be based in Ladenburg’s New York office.
Mr. Strupp joins Ladenburg from Rodman & Renshaw, LLC, where he served as a Managing Director, Healthcare Investment Banking, and led efforts expanding the firm’s scope of financing transactions and broadening its client base. Mr. Strupp had served previously served as Partner and Head of Healthcare Investment Banking at ThinkEquity Partners, and a Director of the Global Healthcare Group, Investment Banking Division, at Salomon Smith Barney Inc. Mr. Strupp received a B.A. in Economics from Bates College, and a M.S. in Economics from the London School of Economics.
Dr. Phillip Frost, Chairman of Ladenburg Thalmann Financial Services, said, “Ladenburg is pleased to add someone of David’s caliber to our already talented investment banking team, as we see substantial opportunity to continue to expand our efforts in the healthcare sector, a space we know well. In addition to Ladenburg’s growing investment banking and research capabilities, the firm has robust institutional distribution and a leading network of 2,700 independent financial advisors.”
“We’re excited to welcome David to Ladenburg, as his depth and breadth of experience in the healthcare sector will be an invaluable asset to our Firm,” said David Rosenberg, Co-President and Chief Executive Officer of Ladenburg Thalmann & Co. Inc. “David has particular expertise advising life sciences, biotechnology, specialty pharmaceutical, medical technology and diagnostics companies, and we’re confident that he will make important contributions to Ladenburg’s future success.”Mr. Strupp said, “At a time when Ladenburg is extremely well-positioned for future growth in the space, I am thrilled to be joining the Firm and look forward to working with the talented team to expand its existing healthcare practice.”
Check Out Our Best Services for Investors
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts